Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

Cancer immunotherapy with human γδ T cells expressing Vγ2Vδ2 T cell receptor (also termed Vγ9Vδ2) has shown promise because of their ability to recognize and kill most types of tumors in a major histocombatibility complex (MHC) ‐unrestricted fashion that is independent of the number of tumor mutatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Tanaka, Yoshimasa, Murata‐Hirai, Kaoru, Iwasaki, Masashi, Matsumoto, Kenji, Hayashi, Kosuke, Kumagai, Asuka, Nada, Mohanad H., Wang, Hong, Kobayashi, Hirohito, Kamitakahara, Hiroshi, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Toi, Masakazu, Morita, Craig T.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834800/
https://ncbi.nlm.nih.gov/pubmed/29288540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13491
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars